AlphaLens

TERMINAL

ANALYSIS

Heatmap Stock Lists AlphaBrain Compare Track Record News Rumor Radar Calendar Macro Leaderboard ETF X-Ray Learn

MY SPACE

Dashboard Watchlist Portfolio Achievements Settings

QUICK ACCESS

AAPLApple MSFTMicrosoft NVDANVIDIA GOOGLAlphabet AMZNAmazon TSLATesla

Home Screener Watchlist Account

v12

TICKER Dashboard Screener Macro

UTC ●

LOADING MARKET DATA… │ UTC ●

Loading page…

Screener·Stocks·Lists·Heatmap·Top Picks·Deep-Dives·AlphaBrain·Track Record·Accountability·News·Rumor Radar·Compare·Learn·Free SEC Filings·Pricing·FAQ·Terms·Privacy

AlphaLens provides algorithmic financial data and pre-computed AI analysis for educational and informational purposes only. AlphaScore™, TSI™, EQS™, AlphaMomentum™, Close-vs-Gap Pressure, CER™, Volatility Regime™, Earnings Execution™, Macro Regime Detector™, Portfolio Health Engine™, and Similarity Engine™ are proprietary mathematical algorithms. No output constitutes investment advice or a guarantee of future performance. Conduct independent research. Consult a licensed financial advisor.

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company

Healthcare

$59.12

-0.77%

nightly snapshot · 10/11/2026

ALPHASCORE™ · B · Watch

ALPHASCORE

/ 100

WATCH

▲ 0 · 30D

KEY FUNDAMENTALS

P/E13.0

ROE38.2%

NET MARGIN14.6%

GROSS MARGIN71.1%

MKT CAP$120.77B

loading full analysis…

DAILY BRIEF

Bristol-Myers Squibb Company records an AlphaScore of 63/100. Important metrics include a robust gross margin of 71.08% and a high return on equity (ROE) of 38.19%. A key strength is its dividend of 4.23, while a primary risk is the negative revenue growth of -0.22%.

Written 11/10/2026, 00:24:09 UTC · Snapshot 11/10/2026